Stock listing

Tokyo:4583 Chiome Bioscience Inc. (カイオム・バイオサイエンス) 株価

Follow Chiome Bioscience Inc. into a list and get an email when it puts out news.

Chiome Bioscience Inc. logo
Ticker
Tokyo:4583
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

Non-Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30,2026

Aug 13, 2026

Announcement of target-specific research and option agreement with Heidelberg Pharma

Jul 13, 2022

Service agreement with option contract with Rohto Pharmaceutical Co., Ltd.

Jul 11, 2022

First patient in of cancer therapeutic antibody CBA-1535 in a Phase 1 clinical trial

Jul 4, 2022

Conclusion of contract with additional institutes and first dosing of CBA-1205 in the second part of Phase 1 study

Jun 13, 2022

Submission of the application for a Phase I study of CBA-1535

Feb 16, 2022

License agreement for a diagnostic kit with Fujirebio, Inc.

Feb 15, 2022

Supplementary Information for Financial Results FY12/21

Feb 14, 2022

Non-Consolidated Financial Results (Japanese GAAP) for the Fiscal Year Ended December 31, 2021

Feb 14, 2022

Move to the second half part of Phase 1 clinical trial of first-in-class CBA-1205

Dec 24, 2021

All Chiome Bioscience Inc. news

Chiome Bioscience Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 20 in all · newest Aug 13, 2026 · oldest 2020

Log in to ask 6ix AI your own questions about Chiome Bioscience Inc.